Page last updated: 2024-09-03

tryptophan methyl ester and Astrocytoma, Grade IV

tryptophan methyl ester has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahlstedt, J; Ceberg, C; Chakwizira, A; Nittby Redebrandt, H	1

Other Studies

1 other study(ies) available for tryptophan methyl ester and Astrocytoma, Grade IV

Article	Year
Mathematical modelling of the synergistic combination of radiotherapy and indoleamine-2,3-dioxygenase (IDO) inhibitory immunotherapy against glioblastoma. The British journal of radiology, 2018, Volume: 91, Issue:1087 Topics: Animals; Combined Modality Therapy; Disease Models, Animal; Dose Fractionation, Radiation; Glioblastoma; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Models, Theoretical; Rats; Rats, Inbred F344; Tryptophan	2018

Article

Year

Mathematical modelling of the synergistic combination of radiotherapy and indoleamine-2,3-dioxygenase (IDO) inhibitory immunotherapy against glioblastoma.

The British journal of radiology, 2018, Volume: 91, Issue:1087

Topics: Animals; Combined Modality Therapy; Disease Models, Animal; Dose Fractionation, Radiation; Glioblastoma; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Models, Theoretical; Rats; Rats, Inbred F344; Tryptophan

2018